Life Sciences Tools and Services
Company Overview of Clinipace Worldwide, Inc.
Clinipace Worldwide, Inc. provides digital contract research solutions to pharmaceutical, biotechnology, and medical device companies. It offers drug and clinical development, regulatory and strategic development, and medical device development services in various therapeutic areas, such as oncology/hematology, infectious diseases, cardiometabolic diseases, obstetrics, gynecology, urology, central nervous system, immunology, orthopedic, gastroenterology, nephrology, immunology, and vaccines, as well as eye, ear, and respiratory diseases. The company also provides biostatistics, clinical monitoring, data management, good clinical practice training, GxP auditing and QA consultancy, medical aff...
3800 Paramount Parkway
Morrisville, NC 27560
Founded in 2003
Key Executives for Clinipace Worldwide, Inc.
Co-Founder, CEO & Director
Co-Founder, President and General Counsel
Chief Executive Officer of European Operations
Compensation as of Fiscal Year 2017.
Clinipace Worldwide, Inc. Key Developments
Clinipace Worldwide Names Steve Skolsky to the Board of Directors
Aug 31 17
Clinipace Worldwide has named industry veteran Steve Skolsky to its Board of Directors. Skolsky, who is Principal of Expis Partners, has more than 30 years’ experience in the pharma, biotech, CRO and health care services sectors. From 2011-2016, he held senior executive roles at Quintiles, most recently as Senior Vice President and Managing Director. From 2004 to 2011, Skolsky served as Chief Executive Officer in both private and publically traded biotech companies.
Clinipace Worldwide Launches RSD Global Consulting
Aug 3 17
Clinipace Worldwide launched a new regulatory and strategic development consultancy called RSD Global Consulting (RSDGC). With more than 50 specialists, Clinipace RSD Global Consulting provides strategic consulting and regulatory support in the United States, Europe, and Asia Pacific. RSDGC offers stage-specific solutions for all phases of development, from non-clinical and clinical, through to marketing applications and post-marketing support. The group also provides all aspects of pharmaceutical development support, including chemistry, manufacturing, and controls (CMC) strategy; dossier preparation; pre-approval inspection (PAI) preparation; GxP auditing for compliance in pre-clinical (GLP), clinical (GCP), manufacturing (GMP), medical/regulatory writing, strategic biostatistics and a quality assurance (QA) consultancy.
Clinipace Worldwide Hires Eric B. Grossman, MD, as Vice President and Medical Director
May 18 17
Clinipace Worldwide appointed Eric B. Grossman, MD, as Vice President and Medical Director.
An eminent nephrologist with over 30 years of industry and clinical experience, Dr. Grossman brings almost two decades of experience designing and conducting clinical studies for FDA submission and top-tier journal publication. Prior to joining Clinipace in April 2017, Dr. Grossman was most recently a consultant to the pharmaceutical industry with Bexon Clinical Consulting.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|